Resiliva

Sobre este medicamento

Originator: REZDIFFRA by Madrigal Pharmaceuticals · Manufacturer: Everest Pharma. Indication & Dosage: Resiliva (Resmetirom), generic REZDIFFRA is a prescription medicine used to treat of adults diagnosed with noncirrhotic nonalcoholic steatohepatitis (NASH) accompanied by moderate to advanced liver fibrosis. NASH involves the accumulation of fat in the liver, which leads to inflammation and potentially severe liver complications over time. It improves fibrosis by at least one stage with no worsening of the NAFLD activity score. Resolves NASH with no worsening of fibrosis. Resmetirom functions by reducing hepatic fat accumulation, potentially halting disease progression. It Reduces hepatic fat content, elevaled liver enzymes, and fibrosis biomarkers in NASH patients. Resiliva manufactured by Everest Pharma Ltd. in Bangladesh. Resmetirom has to take orally once daily with or without food as directed by patient’s doctor. ** <100 kg, the recommended dosage is 80 mg orally once daily. ** ≥100 Side Effects: The most common side effects of Resmetirom are: Diarrhea, nausea, vomiting, itching, or dizziness. The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.